Araris Biotech competitorsClear all

Araris Biotech's top competitors include ADC Therapeutics, Mersana Therapeutics, NBE-Therapeutics and MyoKardia.
Araris Biotech
Araris Biotech
Araris Biotech is a biotechnology company with a new antibody-drug conjugate (ADC)-linker technology.
ADC Therapeutics
ADC Therapeutics
ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers.
Mersana Therapeutics
Mersana Therapeutics
Mersana Therapeutics is a clinical stage antibody drug conjugate company.
NBE-Therapeutics
NBE-Therapeutics
NBE-Therapeutics is a privately owned Swiss, Basel-based Biotech company that was founded in 2012 with the vision to develop next-generation ADCs improving treatment options for cancer patients.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Founding Date
Founding Date
2019
Founding Date
2010
Founding Date
2005
Founding Date
2012
Founding Date
2012
Type
Type
Private
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Zürich, CH HQ
Locations
Epalinges, CH HQ
Greater London, GB
New Providence, US
San Mateo, US
Locations
Cambridge, US HQ
Locations
Basel, CH HQ
Locations
South San Francisco, US HQ
Employees
Employees
4
Employees
1041% increase
Employees
8610% increase
Employees
N/A
Employees
1024% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
203.8 m
Valuation ($)
N/A
Valuation ($)
2.2 b
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
727
Twitter followers
N/A
Twitter followers
666
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
12
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
9.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
496038
Alexa Website Rank
420058
Alexa Website Rank
784116
Alexa Website Rank
429920
Alexa Website Rank
378335

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$1.1m (FY, 2018)
Revenue (est.)
$25.2m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$33.6m (FY, 2018)
Net income
Net income
N/A
Net income
($123.1m) (FY, 2018)
Net income
($13.7m) (FY, 2016)
Net income
N/A
Net income
($67.7m) (FY, 2018)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
7 (Apr, 2017)
Patents (US)
N/A
Patents (US)
4 (FY, 2017)
Patents Pending (US)
Patents Pending (US)
N/A
Patents Pending (US)
N/A
Patents Pending (US)
10 (Apr, 2017)
Patents Pending (US)
N/A
Patents Pending (US)
3 (FY, 2017)

Funding

Latest funding round
Latest funding round
$ 2.6m (4 months ago)
Latest funding round
$ 25m (5 months ago)
Latest funding round
N/A
Latest funding round
$ 20.5m (about 3 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 2.6m
Total funding raised
$ 526m
Total funding raised
$ 219.5m
Total funding raised
$ 23.6m
Total funding raised
$ 98m
For sources of this data, please see the company profile

View company profiles

ADC Therapeutics
HQ
Epalinges, CH
Employees
104↑ 1% increase

ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers.

View company
Mersana Therapeutics
HQ
Cambridge, US
Employees
86↑ 10% increase

Mersana Therapeutics is a clinical stage antibody drug conjugate company.

View company
NBE-Therapeutics
HQ
Basel, CH

NBE-Therapeutics is a privately owned Swiss, Basel-based Biotech company that was founded in 2012 with the vision to develop next-generation ADCs improving treatment options for cancer patients.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company